tPA by Endovascular Administration for the Treatment of Submassive PE Using CDT for the Reduction of Thrombus Burden
Clinical trial NCT04248868 · COMPLETED
Trial details
- NCT number
- NCT04248868
- Sponsor
- Thrombolex, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-23
- Primary completion
- 2022-06-22
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.